The free, AI-Powered conversational ChatBot aids in patient Screenings, finding testing centers, answering questions related to the novel coronavirus
San Jose, April 10, 2020: OptraHEALTH®, a leading data-driven intelligence company announced the launch of its HealthFAX.AI: COVID-19 ChatBot, in compliance with CDC guidelines to triage, screen and manage patients based on their symptoms, travel history, age, underlying health conditions, etc. ChatBot consequently identifies high-risk patients and direct them to the nearest testing facility. This informational application also allows its users to connect with its board of healthcare experts instantly.
“The COVID-19 pandemic has caused significant loss of life, chaos and panic. This is our contribution to support the community during this difficult time of global crisis. We have developed COVID-19 ChatBot to keep people informed and safe. We will continue to do everything we can to help protect the vulnerable and help end this pandemic.” said Dr. Gauri Naik, Co-Founder & Chief Executive Officer, OptraHEALTH.
OptraHealth’s AI framework has over 50,000 frequently asked questions about COVID-19. It has over 65 million ontologies to interpret the questions asked by patients using free text. Through this ChatBot, one can also live chat and live call with the physicians. OptraHealth's AI platform connects with organization’s EMR records, clinical notes and medical literature to derive meaningful insights during this pandemic using all the data points gathered conversationally through ChatBot.
OptraHEALTH® is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing our next-generation Artificial Intelligence Platform. OptraHEALTH’s flagship product GeneFAX™ is an AI-powered Knowledge Platform for Genetic Health and is available as a Web Plugin or Mobile application.
Media Inquiries Contacts: